OraSure (OSUR) Wins FDA Approval for OraQuick(R) In-Home HIV Test
Go back to OraSure (OSUR) Wins FDA Approval for OraQuick(R) In-Home HIV Test| OraSure Technologies, Inc. (NASDAQ: OSUR) | Delayed: 3.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.75 | 52 Week High | $9.05 | |||
| Open | $3.75 | 52 Week Low | $5.10 | |||
| Day High | $3.75 | P/E | N/A | |||
| Day Low | $3.75 | EPS | $-0.20 | |||
| Volume | 3 | |||||
